Active Ingredient(s):Brivaracetam FDA Approved: * February 18, 2016 Pharm Company: *UCB INC Category:Anticonvulsant
Brivaracetam, sold under the brand names Briviact and Brivajoy among others, a chemical analog of levetiracetam, is a racetam derivative with anticonvulsant (antiepileptic) properties. It is marketed by the pharmaceutical company UCB. In India it is co-promoted and distributed by Dr. Reddy's Laboratories.[not verified in body]
1 Medical uses
2 Adverse effects
* May have multiple approval dates, manufacturers, or labelers.